# STEREOTAXIS, INC. (STXS) · Edgar & Edgarette company card

> Stereotaxis (STXS) grew revenue 20.3% in FY2025 to $32 million, operating margin -68.3% against a 7.5% median for electromedical & electrotherapeutic apparatus, equity 25.8% of assets. Every figure is from the company’s own annual report filed with the SEC.

SEC CIK 1289340 · fiscal year ended 2025-12-31 · 5 audited years read · [page](https://www.pops4.com/boards/company/STXS) · [JSON](https://www.pops4.com/boards/company/STXS.json)

## Figures, as filed in the 10-K

| Measure | Value |
|---|---|
| Revenue | $32M |
| Revenue growth, 1 year | 20.3% |
| Revenue growth per year | -1.9% |
| Operating margin | -68.3% (prior year -91.9%) |
| Net margin | -66.8% |
| Operating cash flow | −$14M |
| Capital spending | $93,000 |
| Free cash flow | −$14M |
| Cash | $13M |
| Long-term debt | — |
| Total assets | $52M |
| Total equity | $13M |
| Equity ÷ assets | 25.8% |
| Return on equity | -160.5% |
| Dividend per share | — |
| Dividend years rising | — |

## Readings, computed from those figures

- Altman Z: -37.38 (distress zone)
- Piotroski F: 5 of 9 (middling)
- Beneish M: -2.79 (below the −1.78 line)
- Health Harbor boat: Old boat · three warning signs · operating cash flow was negative; operating loss: a margin of -68.3% in FY2025; revenue is hard to predict: its 80% range is ±43%
- Cash Compass: In between · no clear cash pattern yet

## Edgarette's reading

Exposure: revenue $32.4M (FY2025). Experience: revenue up 20.3% on the year, down 1.9% a year over 4 years; operating margin -68.3%, up from -91.9%. Soundness: equity 25.8% of assets, return on equity -160.5%. Credibility: four or more audited years, reasonable weight. Range: 80% of past cases like this landed between $22.6M and $56.2M next year (method v4.1: its own 6-year record of growth weighed at 63% against under $50M filers; across 2019–2025, 69.0% landed inside, 83.4% on the one year the method never saw). In a shock year the stress range is $21.3M to $60.0M. A statistical range, not company guidance. Against peers (13 filers, $50M+ revenue, electromedical & electrotherapeutic apparatus): operating margin -68.3% against a 7.5% median; growth 20.3% against 8.3%.

Range logged 2026-11-01, receipt 35450a126d89a6ab, status open. A statistical range, not company guidance.

## Health Watch, last 12 months

No warning filings in the window.

## Recent filings

- 8-K · filed 2026-11-10 · 1.01 Entry into a Material Definitive Agreement; 2.02 Results of Operations and Financial Condition; 2.03 Creation of a Direct Financial Obligation; 3.02 Unregistered Sales of Equity Securities; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1289340/000149315226050957/0001493152-26-050957-index.htm)
- 10-Q · filed 2026-08-12 · [filing](https://www.sec.gov/Archives/edgar/data/1289340/000149315226037357/0001493152-26-037357-index.htm)
- 8-K · filed 2026-08-11 · 2.02 Results of Operations and Financial Condition; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1289340/000149315226037113/0001493152-26-037113-index.htm)
- 8-K · filed 2026-07-16 · 8.01 Other Events; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1289340/000149315226033405/0001493152-26-033405-index.htm)
- 8-K · filed 2026-07-09 · 3.02 Unregistered Sales of Equity Securities; 7.01 Regulation FD Disclosure; 8.01 Other Events; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1289340/000149315226032598/0001493152-26-032598-index.htm)
- 8-K · filed 2026-05-15 · 5.07 Submission of Matters to a Vote of Security Holders · [filing](https://www.sec.gov/Archives/edgar/data/1289340/000149315226023654/0001493152-26-023654-index.htm)

## Sources

- facts: https://data.sec.gov/api/xbrl/companyfacts/CIK0001289340.json
- filings: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1289340

## Cite

POPS4, Edgar & Edgarette: STEREOTAXIS, INC. (STXS) company card, from the company's own SEC filings, accessed 2026-11-11, https://www.pops4.com/boards/company/STXS. CC BY 4.0. For a figure, add the filing URL under filings or sources.

DOI https://doi.org/10.5281/zenodo.23672509 · catalog https://www.pops4.com/boards/catalog.json · Figures as filed with the SEC. Card text CC BY 4.0, POPS4.

Reporting, not investment advice. No price targets and no trading recommendations.

Figures are as filed in audited 10-K reports and can move with restatements, acquisitions, disposals or a change in fiscal year. A range set from how past company-years turned out is not a promise about the next one, and says nothing about the share price.